Novel mitochondrial substrates of omi indicate a new regulatory role in neurodegenerative disorders

PLoS ONE

Volumn 4, Issue 9, 2009, Pages

  Johnson, Felicity ^a   Kaplitt, Michael G ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CHAPERONE; HEAT SHOCK PROTEIN 70; ISOCITRATE DEHYDROGENASE (NAD); PYRUVATE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); ROTENONE; SERINE PROTEINASE OMI; CATALASE; ISOCITRATE DEHYDROGENASE; MITOCHONDRIAL PROTEIN; OXYGEN; PYRUVATE DEHYDROGENASE COMPLEX; SERINE PROTEINASE;

ARTICLE; CELL STRAIN HEK293; CITRIC ACID CYCLE; CONTROLLED STUDY; DECARBOXYLATION; DEGENERATIVE DISEASE; ELUTION; EMBRYO; ENZYME ACTIVITY; ENZYME BINDING; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME SUBSTRATE; GENE EXPRESSION PROFILING; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; MASS SPECTROMETRY; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NERVE CELL LESION; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; PROTEOMICS; CELL LINE; CHEMISTRY; GENE EXPRESSION REGULATION; METABOLISM; NERVE CELL; PATHOLOGY; POINT MUTATION; TIME;

MUS; VASCONCELLEA CANDICANS;

CATALASE; CELL LINE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; ISOCITRATE DEHYDROGENASE; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; MOLECULAR CHAPERONES; NEURODEGENERATIVE DISEASES; NEURONS; OXYGEN; POINT MUTATION; PYRUVATE DEHYDROGENASE COMPLEX; ROTENONE; SERINE ENDOPEPTIDASES; TIME FACTORS;

EID: 70349459398     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007100     Document Type: Article

References (41)

1. Faccio L, Fusco C, Chen A, Martinotti S, Bonventre JV, et al. (2000) Characterization of a novel human serine protease that has extensive homology to bacterial heat shock endoprotease HtrA and is regulated by kidney ischemia. J Biol Chem 275: 2581-2588.
2. Huttunen HJ, Guenette SY, Peach C, Greco C, Xia W, et al. (2007) HtrA2 regulates beta-amyloid precursor protein (APP) metabolism through endoplasmic reticulum-associated degradation. J Biol Chem 282: 28285-28295.
3. Seong YM, Choi JY, Park HJ, Kim KJ, Ahn SG, et al. (2004) Autocatalytic processing of HtrA2/Omi is essential for induction of caspase-dependent cell death through antagonizing XIAP. J Biol Chem 279: 37588-37596.
4. Verhagen AM, Silke J, Ekert PG, Pakusch M, Kaufmann H, et al. (2002) HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. J Biol Chem 277: 445-454.
5. Martins LM, Turk BE, Cowling V, Borg A, Jarrell ET, et al. (2003) Binding specificity and regulation of the serine protease and PDZ domains of HtrA2/Omi. J Biol Chem 278: 49417-49427.
6. Vande Walle L, Van Damme P, Lamkanfi M, Saelens X, Vandekerckhove J, et al. (2007) Proteome-wide Identification of HtrA2/Omi Substrates. J Proteome Res 6: 1006-1015.
7. Martins LM, Iaccarino I, Tenev T, Gschmeissner S, Totty NF, et al. (2002) The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif. J Biol Chem 277: 439-444.
8. Li W, Srinivasula SM, Chai J, Li P, Wu JW, et al. (2002) Structural insights into the pro-apoptotic function of mitochondrial serine protease HtrA2/Omi. Nat Struct Biol 9: 436-441.
9. Nam MK, Seong YM, Park HJ, Choi JY, Kang S, et al. (2006) The homotrimeric structure of HtrA2 is indispensable for executing its serine protease activity. Exp Mol Med 38: 36-43.
10. Savopoulos JW, Carter PS, Turconi S, Pettman GR, Karran EH, et al. (2000) Expression, purification, and functional analysis of the human serine protease HtrA2. Protein Expr Purif 19: 227-234.
11. Suzuki Y, Takahashi-Niki K, Akagi T, Hashikawa T, Takahashi R (2004) Mitochondrial protease Omi/HtrA2 enhances caspase activation through multiple pathways. Cell Death Differ 11: 208-216.
12. Suzuki Y, Imai Y, Nakayama H, Takahashi K, Takio K, et al. (2001) A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell 8: 613-621.
13. van Loo G, van Gurp M, Depuydt B, Srinivasula SM, Rodriguez I, et al. (2002) The serine protease Omi/HtrA2 is released from mitochondria during apoptosis. Omi interacts with caspase-inhibitor XIAP and induces enhanced caspase activity. Cell Death Differ 9: 20-26.
14. Zhang X, Chang Z (2004) Temperature dependent protease activity and structural properties of human HtrA2 protease. Biochemistry (Mosc) 69: 687-692.
15. Zhang Y, Appleton BA, Wu P, Wiesmann C, Sidhu SS (2007) Structural and functional analysis of the ligand specificity of the HtrA2/Omi PDZ domain. Protein Sci 16: 1738-1750.
16. Thomas B, Beal MF (2007) Parkinson's disease. Hum Mol Genet 16 Spec No. 2: R183-194.
17. Strauss KM, Martins LM, Plun-Favreau H, Marx FP, Kautzmann S, et al. (2005) Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. Hum Mol Genet 14: 2099-2111.
18. Kawamoto Y, Kobayashi Y, Suzuki Y, Inoue H, Tomimoto H, et al. (2008) Accumulation of HtrA2/Omi in neuronal and glial inclusions in brains with alpha-synucleinopathies. J Neuropathol Exp Neurol 67: 984-993.
19. Simon-Sanchez J, Singleton AB (2008) Sequencing analysis of OMI/HTRA2 shows previously reported pathogenic mutations in neurologically normal controls. Hum Mol Genet.
20. Ross OA, Soto AI, Vilarino-Guell C, Heckman MG, Diehl NN, et al. (2008) Genetic variation of Omi/HtrA2 and Parkinson's disease. Parkinsonism Relat Disord 14: 539-543.
21. Jones JM, Albin RL, Feldman EL, Simin K, Schuster TG, et al. (1993) mnd2: a new mouse model of inherited motor neuron disease. Genomics 16: 669-677.
22. Jones JM, Datta P, Srinivasula SM, Ji W, Gupta S, et al. (2003) Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice. Nature 425: 721-727.
23. Martins LM, Morrison A, Klupsch K, Fedele V, Moisoi N, et al. (2004) Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice. Mol Cell Biol 24: 9848-9862.
24. Moisoi N, Klupsch K, Fedele V, East P, Sharma S, et al. (2008) Mitochondrial dysfunction triggered by loss of HtrA2 results in the activation of a brain-specific transcriptional stress response. Cell Death Differ.
25. Cilenti L, Soundarapandian MM, Kyriazis GA, Stratico V, Singh S, et al. (2004) Regulation of HAX-1 anti-apoptotic protein by Omi/HtrA2 protease during cell death. J Biol Chem 279: 50295-50301.
26. Park HJ, Kim SS, Seong YM, Kim KH, Goo HG, et al. (2006) Beta-amyloid precursor protein is a direct cleavage target of HtrA2 serine protease. Implications for the physiological function of HtrA2 in the mitochondria. J Biol Chem 281: 34277-34287.
27. Yang L, Sun M, Sun XM, Cheng GZ, Nicosia SV, et al. (2007) Akt attenuation of the serine protease activity of HtrA2/Omi through phosphorylation of serine 212. J Biol Chem 282: 10981-10987.
28. Plun-Favreau H, Klupsch K, Moisoi N, Gandhi S, Kjaer S, et al. (2007) The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. Nat Cell Biol.
29. Whitworth AJ, Lee JR, Ho VM, Flick R, Chowdhury R, et al. (2008) Rhomboid-7 and HtrA2/Omi act in a common pathway with the Parkinson's disease factors Pink1 and Parkin. Dis Model Mech 1: 168-174.
30. Exner N, Treske B, Paquet D, Holmstrom K, Schiesling C, et al. (2007) Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin. J Neurosci 27: 12413-12418.
31. Tain LS, Chowdhury RB, Tao RN, Plun-Favreau H, Moisoi N, et al. (2009) Drosophila HtrA2 is dispensable for apoptosis but acts downstream of PINK1 independently from Parkin. Cell Death Differ.
32. Yun J, Cao JH, Dodson MW, Clark IE, Kapahi P, et al. (2008) Loss-of-function analysis suggests that Omi/HtrA2 is not an essential component of the PINK1/PARKIN pathway in vivo. J Neurosci 28: 14500-14510.
33. Klupsch K, Downward J (2006) The protease inhibitor Ucf-101 induces cellular responses independently of its known target, HtrA2/Omi. Cell Death Differ 13: 2157-2159.
34. Cilenti L, Lee Y, Hess S, Srinivasula S, Park KM, et al. (2003) Characterization of a novel and specific inhibitor for the pro-apoptotic protease Omi/HtrA2. J Biol Chem 278: 11489-11494.
35. Kampinga HH, Hageman J, Vos MJ, Kubota H, Tanguay RM, et al. (2009) Guidelines for the nomenclature of the human heat shock proteins. Cell Stress Chaperones 14: 105-111.
36. Flynn JM, Neher SB, Kim YI, Sauer RT, Baker TA (2003) Proteomic discovery of cellular substrates of the ClpXP protease reveals five classes of ClpX-recognition signals. Mol Cell 11: 671-683.
37. Kiang JG, Bowman PD, Lu X, Li Y, Ding XZ, et al. (2006) Geldanamycin prevents hemorrhage-induced ATP loss by overexpressing inducible HSP70 and activating pyruvate dehydrogenase. Am J Physiol Gastrointest Liver Physiol 291: G117-127.
38. Leverenz JB, Umar I, Wang Q, Montine TJ, McMillan PJ, et al. (2007) Proteomic identification of novel proteins in cortical lewy bodies. Brain Pathol 17: 139-145.
39. Jin S, Kalkum M, Overholtzer M, Stoffel A, Chait BT, et al. (2003) CIAP1 and the serine protease HTRA2 are involved in a novel p53-dependent apoptosis pathway in mammals. Genes Dev 17: 359-367.
40. Plun-Favreau H, Gandhi S, Wood-Kaczmar A, Deas E, Yao Z, et al. (2008) What have PINK1 and HtrA2 genes told us about the role of mitochondria in Parkinson's disease? Ann N Y Acad Sci 1147: 30-36.
41. Wigler M, Pellicer A, Silverstein S, Axel R (1978) Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor. Cell 14: 725-731.